Aduhelm: Case Study on Paying for Health by Paul Seegert
Insurance Thought Leadership - Nov 07, 2021
In July, I wrote an article that criticized the newly authorized Alzheimer’s drug Aduhelm. Six months later, the market response is heartening and, in my opinion, a case study in what it will take to fix the way that we pay for healthcare in America. A review of the problem The FDA approved the fi...
Recommended Articles
Posted: Aug 04, 2025
Let's Not Get Carried Away PaulCarroll Mon, 08/04/2025 - 19:49 Recent articles by a...
Posted: Aug 03, 2025
Managing Vendor Risks in Cyber Insurance Cyber ITL Editorial Team Sun, 08/03/2...
Posted: Aug 01, 2025
August 2025 ITL FOCUS: Operational Efficiency Operational Efficiency sradomski...